Firazyr ইউরোপীয় ইউনিয়ন - লাত্‌ভীয় - EMA (European Medicines Agency)

firazyr

takeda pharmaceuticals international ag - icatibant - angioedēma, iedzimta - sirds terapija - firazyr norāda akūtas lēkmes iedzimtām tūska (hae) simptomātiskai ārstēšanai pieaugušajiem (c1 esterase inhibitors trūkumu).

Icatibant Accord ইউরোপীয় ইউনিয়ন - লাত্‌ভীয় - EMA (European Medicines Agency)

icatibant accord

accord healthcare s.l.u. - icatibant acetate - angioedēma, iedzimta - other hematological agents - icatibant accord is indicated for symptomatic treatment of acute attacks of hereditary angioedema (hae) in adults, adolescents and children aged 2 years and older, with c1 esterase inhibitor deficiency.